Researching Early Detection of Ovarian and Endometrial Cancer using High Sensitivity Genomic Assays

Sponsored by: Agilent
C.E. Credits: P.A.C.E. CE Florida CE
Speakers
  • Professor, Department of Obstetrics & Gynecology Department of Oncology, McGill University and Director, Gynecologic Cancer Service McGill University Health Centre
    Biography
      Dr. Lucy Gilbert is a Professor in the Department of Obstetrics & Gynecology and the Department of Oncology at McGill University. She is the Director of Gynecologic Oncology at McGill University and McGill University Health Centre (MUHC), which is a designated level-IV unit that provides gynecological cancer care for the province of Quebec. Dr Gilbert heads the Women’s Health Research Unit of the MUHC, which focuses on research that produces practical and immediate benefits for women with cancer. The Women’s Health Research Unit is active in collaborative multinational clinical trials investigating new precision therapies for gynecologic cancers. However, Dr Gilbert’s main area of interest is the early detection of ovarian and uterine cancers while they are still curable. To this end, she has set up a network of satellite clinics called DOvEE (Diagnosing Ovarian and Endometrial Cancers Early) which provide open access and fast-track investigations to women over 45 with symptoms associated with gynecologic cancers. She and her team have developed a new genetic pap-test called DOvEEgene for detecting these cancers very early before they even cause symptoms. Her team has completed the Phase I & II testing of the DOvEEgene test and is presently set to launch the Phase III.
    • Head of Genome Sciences, McGill University and Génome Québec Innovation Centre
      Biography
        Dr. Ioannis Ragoussis has a BSc/MSc and PhD in Biochemistry from University of Tuebingen. He is Head of Genome Sciences at the McGill Genome Centre responsible for the scientific oversight of its genomics platforms, technical developments and integration. He is Professor at the Department of Human Genetics and in the Department of Bioengineering McGill University since 2013. He established the first Single Cell Genomics Laboratory in Quebec and leads the Advanced Genomics group applying a number of long read and linked read sequencing technologies. He is currently working on genome sequencing technologies and genome assembly, childhood and adult brain cancer, breast cancer, stomach and esophageal cancers, analyzing tumor heterogeneity, identification of progenitor cells, working towards the identification of drug targets. His lab is a member the CRUK Grant Challenge STORMing Cancer project as well as a number of Genome Canada, CFI and CIHR projects. He has >220 authored/co-authored publications.

      Abstract
      Due to unforeseen circumstances, this webinar has been postponed to a further date.
       
      Most deaths from ovarian and endometrial cancer are due to high-grade subtypes that metastasize before they are detectable by available tests. We present DOvEEgene, a genomic capture based uterine-pap test, which can identify prevalent ovarian/endometrial cancers as well as germline mutations predisposing to these cancers using high sensitivity sequencing of genes implicated in ovarian and endometrial carcinogenesis. As pathogenic somatic mutations associated with these cancers are also present in benign disease common in peri/postmenopausal women, we used a machine-learning derived classifier to differentiate cancer from non-cancer. We will present data derived from screening of 584 women in two phases , where we have achieved a sensitivity of 70% (95 % CI 61%-79%) and specificity of 100% (95% CI 96-100%). DOvEEgene, shows promise as a screening test as it can detect prevalent endometrial/ovarian cancers as well as hereditary predisposition to these cancers in peri/postmenopausal women.
       
       
      Learning Objectives:
       
      Part A
      • Develop an understanding of the public health issues related to endometrial and ovarian cancer
      • Understanding of study design considerations for gynecological cancer screening
      • Understanding of tissue sampling approaches

      Part B

      • Insight in genomic approaches to detect cancer associate somatic mutations
      • Understanding of next generation sequencing based methodologies allowing the detection of somatic mutations with high sensitivity
      • Understanding of gene panel design considerations
      • Understanding of next generation sequencing data analysis approaches

      Joint

      • Understanding of data interpretation approaches and modelling
       
      For Research Use Only. Not for use in diagnostic procedures. 
       
      Webinars will be available for unlimited on-demand viewing after live event.
       
      LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

      Show Resources
      You May Also Like
      SEP 10, 2020 9:00 AM PDT
      C.E. CREDITS
      SEP 10, 2020 9:00 AM PDT
      Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
      NOV 16, 2020 8:00 AM PST
      C.E. CREDITS
      NOV 16, 2020 8:00 AM PST
      Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
      OCT 29, 2020 6:00 AM PDT
      C.E. CREDITS
      OCT 29, 2020 6:00 AM PDT
      Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
      NOV 18, 2020 8:00 AM PST
      C.E. CREDITS
      NOV 18, 2020 8:00 AM PST
      DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
      NOV 10, 2020 7:00 AM PST
      C.E. CREDITS
      NOV 10, 2020 7:00 AM PST
      DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
      SEP 03, 2020 9:00 AM PDT
      C.E. CREDITS
      SEP 03, 2020 9:00 AM PDT
      DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
      Loading Comments...
      Show Resources
      Event Countdown
      • 0 Days
      • 0 Hours
      • 0 Minutes
      • 0 Seconds
      Attendees
      • See more